Enables actin filament binding activity; cytoskeletal motor inhibitor activity; and myosin binding activity. Involved in actin cytoskeleton organization and negative regulation of muscle filament sliding. Located in I band; stress fiber; and striated muscle thin filament. Part of actomyosin, myosin complex part. Expressed in several structures, including non-striated muscle; pharynx; spermatheca; ventral ganglion; and vulva.
Predicted to enable carbohydrate binding activity. Predicted to be located in external side of plasma membrane. Is an ortholog of human CLEC2L (C-type lectin domain family 2 member L); KLRB1 (killer cell lectin like receptor B1); and KLRG1 (killer cell lectin like receptor G1).
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in central nervous system development; neuron differentiation; and regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. Expressed in head neurons; rectal gland cell; and tail neurons.